Literature DB >> 18953475

Protective action of intravesical oxybutynin on bladder ultrastructure in rabbits with detrusor overactivity.

Hamilto Yamamoto1, Paulo Roberto Kawano, Karina Tuma Balasteghin, Carlos Roberto Padovani, João Luiz Amaro.   

Abstract

To evaluate the protective effect of intravesical oxybutynin on the ultrastructure of rabbits with detrusor overactivity (DO). Seventeen North Folk male rabbits were distributed into three groups: GI (n = 5) used as control, GII (n = 5), and GIII (n = 5) with DO. One animal from GII and one from GIII were excluded because they did not develop DO. In GIII, the animals were treated with daily intravesical application of 0.5 mg/Kg of oxybutynin for 30 days. Bladder weight was significantly higher in animals from GII and GIII as compared to GI. After 30 days, cystometric study revealed that vesical capacity was significantly decreased in GII and GIII. Detrusor pressure was significantly higher in GII. Electron microscopy showed increase of intercellular space, cell junctions and caveolae areas asymmetries, mitochondria and cellular degeneration in GII, while in GIII, these alterations have improved after a 30-day treatment. Animals treated with intravesical oxybutynin presented ultrastructural aspect similar to normal.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18953475     DOI: 10.1007/s00192-008-0745-1

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  19 in total

1.  The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

Authors:  Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip van Kerrebroeck; Arne Victor; Alan Wein
Journal:  Neurourol Urodyn       Date:  2002       Impact factor: 2.696

2.  Experimental model of bladder instability in rabbits.

Authors:  K T Balasteghin; A M Nardo; J L Amaro; C R Padovani
Journal:  Int Braz J Urol       Date:  2003 Jan-Feb       Impact factor: 1.541

3.  Intravesical oxybutynin for neurogenic bladder dysfunction: less systemic side effects due to reduced first pass metabolism.

Authors:  G Buyse; K Waldeck; C Verpoorten; H Björk; P Casaer; K E Andersson
Journal:  J Urol       Date:  1998-09       Impact factor: 7.450

4.  Correlation of ischemia/reperfusion or partial outlet obstruction-induced spectrin proteolysis by calpain with contractile dysfunction in rabbit bladder.

Authors:  Y Zhao; S S Levin; A J Wein; R M Levin
Journal:  Urology       Date:  1997-02       Impact factor: 2.649

5.  Topical effect of intravesical oxybutynin.

Authors:  W W Bonney; R A Robinson; R J Theobald
Journal:  J Urol       Date:  1993-11       Impact factor: 7.450

6.  Metabolic basis for contractile dysfunction following chronic partial bladder outlet obstruction in rabbits.

Authors:  D A Nigro; N Haugaard; A J Wein; R M Levin
Journal:  Mol Cell Biochem       Date:  1999-10       Impact factor: 3.396

7.  Time-dependent remodeling of the bladder wall in growing rabbits after partial outlet obstruction.

Authors:  F Pampinella; M Roelofs; E Castellucci; G Passerini-Glazel; F Pagano; S Sartore
Journal:  J Urol       Date:  1997-02       Impact factor: 7.450

8.  Structural and vascular response of normal and obstructed rabbit whole bladders to distension.

Authors:  Seiji Matsumoto; Paul Chichester; Barry A Kogan; Robert M Levin
Journal:  Urology       Date:  2003-12       Impact factor: 2.649

9.  Definition and epidemiology of overactive bladder.

Authors:  Alan J Wein; Eric S Rovner
Journal:  Urology       Date:  2002-11       Impact factor: 2.649

10.  Structural basis of geriatric voiding dysfunction. III. Detrusor overactivity.

Authors:  A Elbadawi; S V Yalla; N M Resnick
Journal:  J Urol       Date:  1993-11       Impact factor: 7.450

View more
  2 in total

1.  Intravesical oxybutynin protects the vesical wall against functional and smooth muscle changes in rabbits with detrusor overactivity.

Authors:  Armando Polido Júnior; José Mateus Costa; Tânia Munhoz; Francisco José Sampaio; Luiz Eduardo Macedo Cardoso; João Luiz Amaro
Journal:  Int Urogynecol J       Date:  2010-07-14       Impact factor: 2.894

Review 2.  Intravesical oxybutynin in the pediatric neurogenic bladder.

Authors:  John Lazarus
Journal:  Nat Rev Urol       Date:  2009-11-10       Impact factor: 14.432

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.